AI assistant
VOLITIONRX LTD — Director's Dealing 2017
Apr 19, 2017
34395_dirs_2017-04-19_53957681-a1e2-437b-8805-790394007424.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-04-18
Reporting Person: Innes Guy Archibald (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-04-18 | Common Stock | X | 74821 | $2.6 | Acquired | 1304975 | Direct |
| 2017-04-18 | Common Stock | X | 1786 | $2.6 | Acquired | 49726 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-18 | Warrant (Right to Buy) | $2.6 | X | 74821 | Disposed | 2017-05-10 | Common Stock (74821) | Direct |
| 2017-04-18 | Warrant (Right to Buy) | $2.6 | X | 1786 | Disposed | 2017-05-10 | Common Stock (1786) | Indirect |
Footnotes
F1: On April 18, 2017, the Reporting Person exercised a warrant to purchase 74,821 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017.
F2: On April 18, 2017, a bare trust, of which the Reporting Person is the Trustee, exercised a warrant to purchase 1,786 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017.
F3: The foregoing shares and warrants are held by a bare trust, which is not a separate legal entity, of which Mr. Innes is the Trustee, for the benefit of certain minors.